Herve Watier

Tours, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications

Is Unmutated IgG1 a Wrong Choice for Therapeutic Antibodies Targeting Immune Checkpoints? Lessons From the Clinical Failures of the First Anti-TIGIT Antibodies.

Is Unmutated IgG1 a Wrong Choice for Therapeutic Antibodies Targeting Immune Checkpoints? Lessons From the Clinical Failures of the First Anti-TIGIT Antibodies.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 21, 2026

Clinical usefulness of anti-α3Gal immunoglobulin E assays for cetuximab-mediated anaphylaxis in head and neck cancer.

Clinical usefulness of anti-α3Gal immunoglobulin E assays for cetuximab-mediated anaphylaxis in head and neck cancer.

Journal: Immuno-oncology technology
Published: March 19, 2025

From the Gorgon's blood to Behring's Blutserumtherapie: A long path towards serum therapy.

From the Gorgon's blood to Behring's Blutserumtherapie: A long path towards serum therapy.

Journal: Immunological reviews
Published: September 14, 2024

Bispecific antibodies tethering innate receptors induce human tolerant-dendritic cells and regulatory T cells.

Bispecific antibodies tethering innate receptors induce human tolerant-dendritic cells and regulatory T cells.

Journal: Frontiers in immunology
Published: January 11, 2024

Albumin influences leucocyte FcRn expression in the early days of kidney transplantation.

Albumin influences leucocyte FcRn expression in the early days of kidney transplantation.

Journal: Clinical and experimental immunology
Published: July 26, 2023

10th antibody industrial symposium: new developments in antibody and adoptive cell therapies.

10th antibody industrial symposium: new developments in antibody and adoptive cell therapies.

Journal: mAbs
Published: May 15, 2023

Is there any revival of the use of plasma therapy or neutralizing convalescent antibody therapy to treat SARS-CoV-2 variants and are we rethinking preparedness plans?

Is there any revival of the use of plasma therapy or neutralizing convalescent antibody therapy to treat SARS-CoV-2 variants and are we rethinking preparedness plans?

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
Published: May 11, 2023

Why is there no biosimilar of Erbitux®?

Why is there no biosimilar of Erbitux®?

Journal: Journal of pharmaceutical and biomedical analysis
Published: April 28, 2023

Harnessing Fc/FcRn Affinity Data from Patents with Different Machine Learning Methods.

Harnessing Fc/FcRn Affinity Data from Patents with Different Machine Learning Methods.

Journal: International journal of molecular sciences
Published: February 07, 2023

Monoclonal Antibody Engineering and Design to Modulate FcRn Activities: A Comprehensive Review.

Monoclonal Antibody Engineering and Design to Modulate FcRn Activities: A Comprehensive Review.

Journal: International journal of molecular sciences
Published: August 04, 2022

Finding the Right Heavy Chains for Immunostimulatory Antibodies.

Finding the Right Heavy Chains for Immunostimulatory Antibodies.

Journal: International journal of molecular sciences
Published: August 02, 2022

A New in Silico Antibody Similarity Measure Both Identifies Large Sets of Epitope Binders with Distinct CDRs and Accurately Predicts Off-Target Reactivity.

A New in Silico Antibody Similarity Measure Both Identifies Large Sets of Epitope Binders with Distinct CDRs and Accurately Predicts Off-Target Reactivity.

Journal: International journal of molecular sciences
Published: August 01, 2022
Showing 1-12 of 70

Last Updated: 09/26/2026